InfuSystem Holdings (INFU) Net Income towards Common Stockholders (2010 - 2026)

InfuSystem Holdings (INFU) reported Net Income towards Common Stockholders of $1.0 million for Q1 2026, up 600.0% on a YoY basis from $142857.1 in Q1 2025, and down 51.5% quarter-over-quarter from $2.1 million in Q4 2025.

InfuSystem Holdings (INFU) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

InfuSystem Holdings has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $1.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 600.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.9 million (up 142.36% YoY), and the FY2025 full-year result was $6.6 million, up 182.6% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $1.0 million, down from $2.1 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $2.6 million in Q2 2025, with the low at -$1.1 million in Q1 2024.
  • Historically, Net Income towards Common Stockholders has averaged $647117.6 across 5 years, with a median of $443000.0 in 2022.
  • The largest YoY upside for Net Income towards Common Stockholders was 1879.17% in 2024 against a maximum downside of 243.21% in 2024.
  • InfuSystem Holdings' Net Income towards Common Stockholders stood at $107000.0 in 2022, then tumbled by 55.14% to $48000.0 in 2023, then jumped by 1879.17% to $950000.0 in 2024, then soared by 117.05% to $2.1 million in 2025, then plunged by 51.5% to $1.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $1.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 InfuSystem Holdings 189.78 Mn 187.68 Mn 19.68 Mn 1.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00 Mn
Dec 31, 2025 2.06 Mn
Sep 30, 2025 2.23 Mn
Jun 30, 2025 2.65 Mn
Mar 31, 2025 -200,000.00
Dec 31, 2024 950,000.00
Sep 30, 2024 1.81 Mn
Jun 30, 2024 717,000.00
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 48,000.00
Sep 30, 2023 689,000.00
Jun 30, 2023 435,000.00
Mar 31, 2023 -324,000.00
Dec 31, 2022 107,000.00
Sep 30, 2022 443,000.00
Jun 30, 2022 -164,000.00
Mar 31, 2022 -330,000.00
Dec 31, 2021 361,000.00
Sep 30, 2021 -448,000.00
Jun 30, 2021 820,000.00